ATS's Radiopharma Business Emerges as Key Growth Engine — Market Talk

RBC says that while Life Sciences remains automation company ATS's primary focus, its radiopharma sub-segment, which covers diagnostics, therapeutics and radioisotopes, is emerging as an important growth driver. Analyst Sabahat Khan says in a note that ATS has historically been involved with diagno…